Relationship between kidney function decline and initial risk factors for the progression of diabetic kidney disease: a retrospective analysis of 91 Japanese patients with type 2 diabetes

被引:3
作者
Ishizuka T. [1 ]
Tokuyama Y. [2 ]
Horie A. [3 ]
Hatanaka Y. [3 ]
Sato S. [1 ]
Kanatsuka A. [3 ]
机构
[1] Sato Clinic, 2138-1 Wakamatsu-cho, Wakaba-ku, Chiba
[2] Kashiwado Hospital, 2-21-8 Nagasu, Chuo-ku, Chiba
[3] Chiba Central Medical Center, Diabetes Center, 1835-1 Kasori-cho, Wakaba-ku, Chiba
关键词
Bilirubin; Diabetic kidney disease; eGFR decline rate; High-density lipoprotein cholesterol; Multivariate linear regression analysis;
D O I
10.1007/s13340-016-0270-2
中图分类号
学科分类号
摘要
Background: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) in Japan. The clinical course and factors related to the progression of DKD to ESRD are important issues when treating patients with DKD. Methods: Ninety-one type 2 diabetic patients with DKD that had progressed from chronic kidney disease (CKD) stages G1–3 on their initial clinical visit to ESRD were enrolled. The decline in the estimated glomerular filtration rate (eGFR) was analyzed and the initial clinical factors that influenced the decline rate were explored. Results: There was a linear decline in eGFR before progression to ESRD, with a median annual decline rate (∆eGFR) of 9.2 mL/min/1.73 m2. In all patients, a history of coronary artery disease and increased levels of initial eGFR and high-density lipoprotein cholesterol (HDL-C) were positive predictors of log ∆eGFR, whereas age, history of cerebral infarction (CI), and an increased level of serum albumin were negative predictors of log ∆eGFR. In patients with CKD stages G1–2 on their first visit, male sex and increased diastolic blood pressure were positive predictors. In patients with CKD stage G3 on their first visit, an increased level of LDL-C was a positive predictor, whereas a history of CI and an increased level of serum total bilirubin (TBil) were negative predictors. Conclusion: In addition to the common risk factors, initial eGFR, HDL-C, and TBil were identified as novel risk factors for ESRD. These risk factors may differ between patients with early and advanced stages of CKD. © 2016, The Japan Diabetes Society.
引用
收藏
页码:432 / 439
页数:7
相关论文
共 32 条
[1]  
Nakai S., Watanabe Y., Masakane I., Wada A., Shoji T., Hasegawa T., Overview of regular dialysis treatment in Japan (as of 31 December 2011), Ther Apher Dial, 17, pp. 567-611, (2013)
[2]  
Molitch M., DeFronzo R., Franz M., Keane W., Mogensen C.E., Parving H.H., Et al., Nephropathy in diabetes, Diabetes Care, 27, pp. S579-S583, (2004)
[3]  
Skupien J., Warram J.H., Smiles A.M., Niewczas M.A., Gohda T., Pezzolesi M.G., Et al., The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease, Kidney Int, 82, pp. 589-597, (2012)
[4]  
Krolewski A.S., Niewczas M.A., Skupien J., Gohda T., Smiles A., Eckfeldt J.H., Et al., Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria, Diabetes Care, 37, pp. 226-234, (2014)
[5]  
Krolewski A.S., Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes, Diabetes Care, 38, pp. 954-962, (2015)
[6]  
Clinical practice guideline for the evaluation and management of chronic kidney disease, Kidney Int, 2013, (2012)
[7]  
Sheen Y.-J., Sheu W.H., Risks of rapid decline renal function in patients with type 2 diabetes, World J. Diabetes., 5, pp. 835-846, (2014)
[8]  
KDOQI clinical practice guideline for diabetes and CKD: 2012 update, Am J Kidney Dis, 60, pp. 850-886, (2012)
[9]  
Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., Et al., Revised equations for estimated GFR from serum creatinine in Japan, Am J Kidney Dis, 53, pp. 982-992, (2009)
[10]  
Fukuda M., Classification and treatment of diabetic retinopathy, Diabetes Res Clin Pract, 24, pp. S171-S176, (1994)